Transaction Documents Sample Contracts
ARTICLE I.Transaction Documents • March 20th, 2001 • Cap Rock Energy Corp • Electric services
Standard Contracts
AMENDMENT NO. 1 TO TRANSACTION DOCUMENTSTransaction Documents • May 27th, 2021 • Grom Social Enterprises, Inc. • Services-computer programming, data processing, etc.
This AMENDMENT NO. 1 TO TRANSACTION DOCUMENTS (this “Amendment”), dated as of May 24, 2021, by and between GROM SOCIAL ENTERPRISES, Inc., a Florida corporation (the “Company”), and EMA FINANCIAL, LLC, a Delaware limited liability company (the “Lender”). Each of the Company and the Lender shall be referred to collectively as the “Parties” and individually as a “Party.”
FIFTH AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • January 10th, 2012 • Urigen Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This FIFTH AMENDMENT TO TRANSACTION DOCUMENTS (this “Amendment”) is made as of the 5th day of October 2011, by and between URIGEN PHARMACEUTICALS, INC., a Delaware corporation with its principal place of business at 1700 North Broadway, Suite 330, Walnut Creek, CA 94596 (the “Borrower”), Urigen N.A., Inc., a Delaware corporation with its principal place of business at 1700 North Broadway, Suite 330, Walnut Creek, CA 94596 (the “Guarantor”), and PLATINUM-MONTAUR LIFE SCIENCES, LLC, a Delaware limited liability company (the “Lender”).
AMENDMENT #1Transaction Documents • September 22nd, 2020 • Success Entertainment Group International Inc. • Services-miscellaneous amusement & recreation • Nevada
THIS AMENDMENT #1 to the Transaction Documents (as defined below) (the “Amendment”) is entered into on September 14, 2020 (the “Effective Date”), by and between Success Entertainment Group International Inc., a Nevada corporation (the “Company”), and Peak One Opportunity Fund, LP (the “Investor”) (collectively the “Parties”).
Eleventh Amendment to Transaction DocumentsTransaction Documents • May 6th, 2024 • Curative Biotechnology Inc • Biological products, (no disgnostic substances)
This Eleventh Amendment to the Transaction (this “Amendment”) is effective as of April 5, 2023 (“Effective Date”), by and between Puritan Partners LLC, a New York limited liability company (“Puritan Partners”) and Curative Biotechnology, Inc., a Florida corporation (the “Company”), having its principal place of business at 1825 NW Corporate Blvd., Suite 110 Boca Raton, FL 33431, each a “Party” and collectively the “Parties”. Capitalized terms used herein without definition shall have the meanings ascribed to them in the Securities Purchase Agreement, dated as of March 2, 2022, as amended, entered between the Parties (the “Securities Purchase Agreement”)
AMENDMENT NO. 1 TO TRANSACTION DOCUMENTSTransaction Documents • May 27th, 2021 • Grom Social Enterprises, Inc. • Services-computer programming, data processing, etc.
This AMENDMENT NO. 1 TO TRANSACTION DOCUMENTS (this “Amendment”), dated as of May 20, 2021, by and between GROM SOCIAL ENTERPRISES, INC., a Florida corporation (the “Company”), and FIRSTFIRE GLOBAL OPPORTUNITIES FUND, LLC, a Delaware limited liability company (the “Lender”). Each of the Company and the Lender shall be referred to collectively as the “Parties” and individually as a “Party.”
AMENDMENT NO. 1 TO TRANSACTION DOCUMENTSTransaction Documents • June 13th, 2008 • FTS Group, Inc. • Knit outerwear mills
AMENDMENT #1Transaction Documents • September 22nd, 2022 • Visium Technologies, Inc. • Services-computer programming services
THIS AMENDMENT #1 to the Transaction Documents (as defined below) (the “Amendment”) is entered into as of September 8, 2022 (the “Effective Date”), by and between Visium Technologies, Inc., a Florida corporation (the “Company”), and ____________________, a Delaware limited liability company (the “Holder”) (collectively the“Parties”).
FIFTH AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • April 2nd, 2015 • UBL Interactive,Inc. • Services-business services, nec • New York
This FIFTH AMENDMENT TO TRANSACTION DOCUMENTS (this “Amendment”) is made as of the 27th day of March 2015, by and among UBL INTERACTIVE, INC. f/k/a NAME DYNAMICS, INC., a Delaware corporation with its principal place of business at 6701 Carmel Road, Suite 202, Charlotte, NC 28226 (the “Borrower”), ALPHA CAPITAL ANSTALT (“Alpha”), WHALEHAVEN CAPITAL FUND LIMITED (“Whalehaven”) and SABLE RIDGE CAPITAL OPPORTUNITY FUND L.P. (“Sable Ridge”) (each a “Lender” or collectively the “Lenders”).
AMENDMENT NO. 1 TO TRANSACTION DOCUMENTSTransaction Documents • June 9th, 2016 • Cannasys Inc • Services-business services, nec
THIS AMENDMENT NO. 1 TO TRANSACTION DOCUMENTS ("Amendment No.1"), is entered into on May 20, 2016 ("Effective Date"), by and among CANNASYS, INC., a Nevada corporation ("CannaSys"), B44, LLC, a Colorado limited liability company ("B44"), and Kodiak Capital Group, LLC, a Delaware limited liability company ("Kodiak") and amends (i) the Assignment of Promissory Notes dated as of March 24, 2016, by and between Kodiak and B44 (the "APN"), (ii) the Wrap-Around Agreement dated as of March 24, 2016, by and between Kodiak and CannaSys (the "WAA") and (iii) the Amended and Restated Promissory Note dated March 24, 2016 issued by CannaSys to Kodiak (the "AARSPN"); the APN, WAA, and the AARSPN are referred to as the "Transaction Documents").
AMENDMENT NO. 1 TO TRANSACTION DOCUMENTSTransaction Documents • August 24th, 2016 • Cannasys Inc • Services-business services, nec
THIS AMENDMENT NO. 1 TO TRANSACTION DOCUMENTS ("Amendment No. 1"), is entered into effective as of the date of the last signature, by and between CANNASYS, INC., a Nevada corporation ("CannaSys"), and Kodiak Capital Group, LLC, a Delaware limited liability company ("Kodiak") and amends: (i) the Securities Purchase Agreement dated as of March 18, 2016, by and between Kodiak and CannaSys (the "SPA"); (ii) the Collateralized Secured Promissory Note dated March 18, 2016, issued by Kodiak to CannaSys (the "Buyer Note"); and (iii) the 12% Convertible Redeemable Promissory Note dated March 18, 2016, issued by CannaSys to Kodiak (the "Second Note"); the SPA, Buyer Note, and Second Note are referred to herein as the "Transaction Documents").
FOURTH AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • December 29th, 2014 • UBL Interactive,Inc. • Services-business services, nec • New York
This FOURTH AMENDMENT TO TRANSACTION DOCUMENTS (this “Amendment”) is made as of the 28th day of November 2014, by and among UBL INTERACTIVE, INC. f/k/a NAME DYNAMICS, INC., a Delaware corporation with its principal place of business at 6701 Carmel Road, Suite 202, Charlotte, NC 28226 (the “Borrower”), ALPHA CAPITAL ANSTALT (“Alpha”), WHALEHAVEN CAPITAL FUND LIMITED (“Whalehaven”) and SABLE RIDGE CAPITAL OPPORTUNITY FUND L.P. (“Sable Ridge”) (each a “Lender” or collectively the “Lenders”).
AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • May 25th, 2017 • First Harvest Corp. • Services-prepackaged software
THIS AMENDMENT (“Amendment”), is entered into on May 23, 2017 (“Effective Date”), by and between FIRST HARVEST CORP., a Nevada corporation (“Borrower”), and EMA FINANCIAL, LLC, a Delaware limited liability company (“Holder”) or its registered assigns or successor in interest. The Borrower and Holder each referred to herein as a “Party” or collectively as the “Parties”.
THIRD AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • October 24th, 2013 • UBL Interactive,Inc. • Services-business services, nec • New York
This THIRD AMENDMENT TO TRANSACTION DOCUMENTS (this “Amendment”) is made as of the 18th day of October 2013, by and between UBL INTERACTIVE, INC. f/k/a NAME DYNAMICS, INC., a Delaware corporation with its principal place of business at 6701 Carmel Road, Suite 202, Charlotte, NC 28226 (the “Borrower”), ALPHA CAPITAL ANSTALT (“Alpha”), WHALEHAVEN CAPITAL FUND LIMITED (“Whalehaven”) and SABLE RIDGE CAPITAL OPPORTUNITY FUND L.P. (“Sable Ridge”) (each a “Lender” or collectively the “Lenders”).
AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • December 31st, 2018 • Reed's, Inc. • Bottled & canned soft drinks & carbonated waters • New York
THIS AMENDMENT TO TRANSACTION DOCUMENTS is entered into and effective as of December 18, 2018 (the “Amendment”) by and between Raptor/ Harbor Reeds SPV LLC, a Delaware limited liability company (“Raptor”), and Reed’s Inc., a Delaware corporation (“Reed’s”).
THIRD AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • May 6th, 2020 • Cleanspark, Inc. • Cogeneration services & small power producers
This Third Amendment to Transaction Documents (“Amendment”) is made and entered into on May 1, 2020 (“Amendment Date”), by and between CleanSpark, Inc., a Nevada corporation, (“Company”), and the investor whose name appears below (“Investor”).
AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • March 10th, 2020 • Cleanspark, Inc. • Cogeneration services & small power producers
This Amendment to Transaction Documents (“Amendment”) is made and entered into on March 4, 2020 (“Amendment Date”), by and between CleanSpark, Inc., a Nevada corporation, (“Company”), and the investor whose name appears below (“Investor”).
SECOND AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • August 20th, 2009 • Urigen Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This SECOND AMENDMENT TO TRANSACTION DOCUMENTS (this “Amendment”) is made as of the 13th day of August 2009, by and between URIGEN PHARMACEUTICALS, INC., a Delaware corporation with its principal place of business at 27 Maiden Lane, Suite 595, San Francisco, California 94108 (the “Borrower”), Urigen N.A., Inc., a Delaware corporation with its principal place of business at 27 Maiden Lane, Suite 595, San Francisco, CA 94108 (the “Guarantor”), and PLATINUM-MONTAUR LIFE SCIENCES, LLC, a Delaware limited liability company (the “Lender”).
AMENDMENT #1Transaction Documents • April 4th, 2022 • Touchpoint Group Holdings Inc. • Telephone & telegraph apparatus
THIS AMENDMENT #1 to the Transaction Documents (as defined below) (the “Amendment”) is entered into as of March 28, 2022 (the “Effective Date”), by and between Touchpoint Group Holdings, Inc., a Delaware corporation (the “Company”), and Talos Victory Fund, LLC, a Delaware limited liability company (the “Holder”) (collectively the “Parties”).
THIRD AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • October 25th, 2017 • Aura Systems Inc • Miscellaneous electrical machinery, equipment & supplies
This THIRD AMENDMENT TRANSACTION DOCUMENTS (this “Amendment”), is effective as of April 8, 2017, (the “Execution Date”) by and among Aura Systems, Inc., a Delaware corporation (the “Company”), and those other persons who have signed the signature page hereto (the “Signatories”), with reference to that certain Securities Purchase Agreement dated May 7, 2013 (as amended, the “Purchase Agreement”) by and among the Company and the Buyers (as that term is defined in the Purchase Agreement). Capitalized terms not defined herein that are defined in the Purchase Agreement shall have the meaning ascribed to them in the Purchase Agreement.
SECOND AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • October 25th, 2017 • Aura Systems Inc • Miscellaneous electrical machinery, equipment & supplies
This SECOND AMENDMENT TRANSACTION DOCUMENTS (this “Amendment”), is entered into this 14th day of March 2017, (the “Execution Date”) by and among Aura Systems, Inc., a Delaware corporation (the “Company”), and those other persons who have signed the signature page hereto (the “Signatories”), with reference to that certain Securities Purchase Agreement dated May 7, 2013 (as amended, the “Purchase Agreement”) by and among the Company and the Buyers (as that term is defined in the Purchase Agreement). Capitalized terms not defined herein that are defined in the Purchase Agreement shall have the meaning ascribed to them in the Purchase Agreement.
FOURTH AMENDMENT TO TRANSACTION DOCUMENTSTransaction Documents • January 10th, 2012 • Urigen Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This FOURTH AMENDMENT TO TRANSACTION DOCUMENTS (this “Amendment”) is made as of the 3rd day of March 2011, by and between URIGEN PHARMACEUTICALS, INC., a Delaware corporation with its principal place of business at 1700 North Broadway, Suite 330, Walnut Creek, CA 94596 (the “Borrower”), Urigen N.A., Inc., a Delaware corporation with its principal place of business at 1700 North Broadway, Suite 330, Walnut Creek, CA 94596 (the “Guarantor”), and PLATINUM-MONTAUR LIFE SCIENCES, LLC, a Delaware limited liability company (the “Lender”).
AMENDMENT #1Transaction Documents • April 4th, 2022 • Touchpoint Group Holdings Inc. • Telephone & telegraph apparatus
THIS AMENDMENT #1 to the Transaction Documents (as defined below) (the “Amendment”) is entered into as of March 25, 2022 (the “Effective Date”), by and between Touchpoint Group Holdings, Inc., a Delaware corporation (the “Company”), and Mast Hill Fund, L.P., a Delaware limited partnership (the “Holder”) (collectively the “Parties”).
AMENDMENT NO. 1 TO TRANSACTION DOCUMENTSTransaction Documents • October 5th, 2006 • Marvel Entertainment, Inc. • Patent owners & lessors • New York
THIS AMENDMENT NO. 1 TO TRANSACTION DOCUMENTS (this “Amendment”) is entered into by and among MVL Film Finance LLC (the “Borrower”), MVL Productions LLC (“MPROD”), Marvel Studios, Inc. (“Marvel Studios”), Marvel Characters, Inc. (“MCI”), MVL Rights LLC (“MRI”), Ambac Assurance Corporation, in its capacity as Control Party (as defined in the Credit Agreement referred to below) (“Ambac”) and HSBC Bank USA, National Association, in its capacity as Collateral Agent (as defined in the Credit Agreement referred to below) (“Collateral Agent”). All capitalized terms used herein without definition shall have the meanings specified in the Credit Agreement referred to below, or, if not defined therein, in the Master Agreement referred to below.
Fourteenth Amendment to Transaction DocumentsTransaction Documents • May 6th, 2024 • Curative Biotechnology Inc • Biological products, (no disgnostic substances)
This Fourteenth Amendment to the Transaction (this “Amendment”) is effective as of December 1, 2023 (“Effective Date”), by and between Puritan Partners LLC, a New York limited liability company (“Puritan Partners”) and Curative Biotechnology, Inc., a Florida corporation (the “Company”), having its principal place of business at 1825 NW Corporate Blvd., Suite 110 Boca Raton, FL 33431, each a “Party” and collectively the “Parties”. Capitalized terms used herein without definition shall have the meanings ascribed to them in the Securities Purchase Agreement, dated as of March 2, 2022, as amended, entered between the Parties (the “Securities Purchase Agreement”).
